These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 29600973

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
    Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K.
    Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
    [Abstract] [Full Text] [Related]

  • 23. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
    Kleski KA, Trabbic KR, Shi M, Bourgault JP, Andreana PR.
    Molecules; 2020 Mar 13; 25(6):. PubMed ID: 32183149
    [Abstract] [Full Text] [Related]

  • 24. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
    Chen M, Lin X, Zhang L, Yu L, Wu Q, Zhang S, Xue F, Huang Y.
    Int J Med Sci; 2020 Mar 13; 17(17):2744-2750. PubMed ID: 33162802
    [Abstract] [Full Text] [Related]

  • 25. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
    Butschak G, Karsten U.
    Tumour Biol; 2002 Mar 13; 23(3):113-22. PubMed ID: 12218291
    [Abstract] [Full Text] [Related]

  • 26. [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates].
    Smorodin EP, Jansson B, Miliukhina L, Paaski G, Bovin NV, Ovchinnikova TV, Kurtenkov O.
    Bioorg Khim; 1997 Oct 13; 23(10):795-9. PubMed ID: 9490614
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model.
    Nemoto-Sasaki Y, Mitsuki M, Morimoto-Tomita M, Maeda A, Tsuiji M, Irimura T.
    Glycoconj J; 2001 Oct 13; 18(11-12):895-906. PubMed ID: 12820723
    [Abstract] [Full Text] [Related]

  • 30. Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors--relation to Lewis (a,b) histo-blood group phenotype.
    Kurtenkov O, Miljukhina L, Smorodin J, Klaamas K, Bovin N, Ellamaa M, Chuzmarov V.
    Acta Oncol; 1999 Oct 13; 38(7):939-43. PubMed ID: 10606423
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.
    Almogren A, Abdullah J, Ghapure K, Ferguson K, Glinsky VV, Rittenhouse-Olson K.
    Front Biosci (Schol Ed); 2012 Jan 01; 4(3):840-63. PubMed ID: 22202095
    [Abstract] [Full Text] [Related]

  • 33. Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.
    Trabbic KR, Bourgault JP, Shi M, Clark M, Andreana PR.
    Org Biomol Chem; 2016 Apr 07; 14(13):3350-5. PubMed ID: 26958987
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
    Kumar SR, Sauter ER, Quinn TP, Deutscher SL.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6868-71. PubMed ID: 16203776
    [Abstract] [Full Text] [Related]

  • 38. The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.
    Ravn P, Stahn R, Danielczyk A, Faulstich D, Karsten U, Goletz S.
    Cancer Immunol Immunother; 2007 Sep 01; 56(9):1345-57. PubMed ID: 17310382
    [Abstract] [Full Text] [Related]

  • 39. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
    Smorodin EP, Kurtenkov OA, Sergeyev BL, Chuzmarov VI, Afanasyev VP.
    Exp Oncol; 2007 Mar 01; 29(1):61-6. PubMed ID: 17431391
    [Abstract] [Full Text] [Related]

  • 40. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
    Dahlenborg K, Hultman L, Carlsson R, Jansson B.
    Int J Cancer; 1997 Jan 06; 70(1):63-71. PubMed ID: 8985092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.